VEGFA and neoplasm: The ability of circulating tumor cells to interact with platelets is deemed to confer a number of advantages for protecting their survival within the circulation and promoting successful metastasis through the secretion of platelet-derived growth factors, transforming growth factor, and vascular endothelial growth factor, which could protect tumor cells from immunological assault and evasion of immune surveillance (25, 26).